PHG News and Press, Koninklijke Philips N.V. NY Registry Shares From 07/27/22

We believe the healthcare sector's strong growth momentum with average revenue growth of 3.8% QoQ indicates a positive outlook, with the equipment industry forecasted at a market CAGR of 5.5%. For the healthcare equipment industry, we believe the outlook is supported by the average gu...

Koninklijke Philips N.V. (PHG) Q2 2022 Results Conference Call July 25, 2022 04:00 AM ET Company Participants Leandro Mazzoni - Head, IR Frans van Houten - CEO Abhijit Bhattacharya - CFO Roy Jakobs - Chief Business Leader, Connected Care Francis Kim - Chi...

U.S. equities wavered on Monday, coming off a positive week for the major averages as traders braced for the busiest week of corporate earnings, as well as insights into further interest rate hikes from the Federal Reserve. The Dow Jones Industrials acquired 95.71 points to reach noon h...

Philips ( NYSE: PHG ) stock continues to be in red following the firm's Q2 earnings announcement and guidance cut that prompted Societe Generale to downgrade the stock to hold from buy. The rating is in line with SA Quant rating of hold , but is in contrast to SA Autho...

The following slide deck was published by Koninklijke Philips N.V. in conjunction with their 2022 Q2 earnings call. For further details see: Koninklijke Philips N.V. 2022 Q2 - Results - Earnings Call Presentation

Gainers: SIGA Technologies SIGA +20% . Tonix Pharmaceuticals TNXP +16% . Chimerix CMRX +13% . Galectin Therapeutics ( GALT ) +7% . Verona Pharma ( VRNA ) +3% . Losers: Enveric Biosciences ( ENVB ) -23% . Koninkli...

Enveric Biosciences ( ENVB ) -20% announces $8M registered direct offering and private placement, priced at a premium to market under Nasdaq rules. Squarespace ( SQSP ) -13% on Q2 results. Baosheng Media Group Holdings ( BAOS ) -12% . Addex ...

Philips ( NYSE: PHG ) stock fell ~10% on July 25 premarket after the company said Q2 sales declined amid supply shortages and prolonged lockdowns in China. Q2 comparable sales declined -7% Y/Y to €4.18B. Adjusted income from continuing operations attribut...

Philips press release ( NYSE: PHG ): Q2 Non-GAAP EPS of €0.14 beats by €0.05 . Revenue of €4.23B (+1.2% Y/Y) beats by €10M . Group sales amounted to EUR 4.2 billion, with a 7% comparable sales decline mainly caused by continued suppl...

July 25, 2022 Highlights Group sales amounted to EUR 4.2 billion, with a 7% comparable sales decline mainly caused by continued supply shortages and prolonged lockdowns in China, on the back of 9% comparable sales growth in Q2 2021 Order book remains strong; comparable o...